MEDICINOVA INC
MNOV · Pharmaceutical Preparations · 49.2M shares · +0%/yr ↑ dilution · EDGAR filings ↗
Net buyback after stock comp: -$1M (gross -$8K, SBC $1M)
Grade
D44Clinical/early-stage biotech — deep losses but funded.
Strengths
- Liquidity — current ratio 8.2 (74th)
Risks
- Pre-revenue, deep losses — per metrics
- Pre-revenue/clinical-stage — history of losses & need for capital per risk factors
- Binary clinical & funding risk — per 10-K
Notable findings
- Net lossNet loss (net margin -2928.8%)
- Cash burnNegative free cash flow (-9.8M)
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC, CITADEL ADVISORS LLC
- Notable holderHeld by 3 notable fund(s): STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC (as of 2026-03-31)
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Operating margin
-3242.5%
Net margin
-2928.8%
Return on equity
-28.9%
Return on assets
-26.3%
Revenue growth (QoQ)
23.2%
Current ratio
8.2×
Free cash flow
-$10M
EBITDA
-$13M
Tangible book value
$32M
Cash & investments
$31M
Cash runway
13q
Stock comp / revenue
202.4%
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-06-24 | Shareholder vote | filing ↗ |
| 2026-02-20 | ResultsExhibits | filing ↗ |
| 2025-12-30 | Material agreementExhibits | filing ↗ |
| 2025-08-01 | Material agreementExhibits | filing ↗ |
| 2025-06-18 | Shareholder vote | filing ↗ |
| 2025-03-11 | Reg FDExhibits | filing ↗ |
| 2024-06-12 | Shareholder vote | filing ↗ |
| 2024-04-01 | Exec/director change | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-24 | 2026-06-23 | 0001193125-26-281171 ↗ |
| 10-Q | 2026-05-14 | 2026-03-31 | 0001193125-26-224066 ↗ |
| 10-K | 2026-03-10 | 2025-12-31 | 0001193125-26-100432 ↗ |
| 8-K | 2026-02-20 | 2026-02-20 | 0001193125-26-060232 ↗ |
| 8-K | 2025-12-30 | 2025-12-29 | 0001193125-25-335917 ↗ |
| 10-Q | 2025-11-12 | 2025-09-30 | 0001193125-25-277779 ↗ |
| 10-Q | 2025-08-14 | 2025-06-30 | 0000950170-25-109041 ↗ |
| 8-K | 2025-08-01 | 2025-07-30 | 0001193125-25-170744 ↗ |
| 8-K | 2025-06-18 | 2025-06-17 | 0000950170-25-087924 ↗ |
| 10-Q | 2025-05-13 | 2025-03-31 | 0000950170-25-070461 ↗ |
| 8-K | 2025-03-11 | 2025-03-11 | 0001193125-25-051990 ↗ |
| 10-K | 2025-02-19 | 2024-12-31 | 0000950170-25-023301 ↗ |